Evidence map›Paper›PMID 34616686›Full record

SynthesisFrontiers in oncology2021

Robotic

Qingbo Feng, Chuang Jiang, Xuping Feng, Yan Du, Wenwei Liao, Hongyu Jin, Mingheng Liao, Yong Zeng, Jiwei Huang

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Frontiers in oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 4 pooled it
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 4 syntheses or guidelines pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Qingbo FengDepartment of Liver Surgery and Liver Transplantation Centre, West China Hospital, Sichuan University, Chengdu, China.
Chuang JiangDepartment of Liver Surgery and Liver Transplantation Centre, West China Hospital, Sichuan University, Chengdu, China.
Xuping FengDepartment of Liver Surgery and Liver Transplantation Centre, West China Hospital, Sichuan University, Chengdu, China.
Yan DuDepartment of Liver Surgery, The First Clinical Medical College of Lanzhou University, Lanzhou, China.
Wenwei LiaoDepartment of Liver Surgery and Liver Transplantation Centre, West China Hospital, Sichuan University, Chengdu, China.
Hongyu JinDepartment of Liver Surgery and Liver Transplantation Centre, West China Hospital, Sichuan University, Chengdu, China.
Mingheng LiaoDepartment of Liver Surgery and Liver Transplantation Centre, West China Hospital, Sichuan University, Chengdu, China.
Yong ZengDepartment of Liver Surgery and Liver Transplantation Centre, West China Hospital, Sichuan University, Chengdu, China.
Jiwei HuangDepartment of Liver Surgery and Liver Transplantation Centre, West China Hospital, Sichuan University, Chengdu, China.
Sichuan University · CNFirst Hospital of Lanzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRobotic distal pancreatectomy (RDP) and laparoscopic distal pancreatectomy (LDP) are the two principal minimally invasive surgical approaches for patients with pancreatic body and tail adenocarcinoma. The use of RDP and LDP for pancreatic ductal adenocarcinoma (PDAC) remains controversial, and which one can provide a better R0 rate is not clear.

methodsA comprehensive search for studies that compared robotic

resultsSix retrospective studies comprising 572 patients (152 and 420 patients underwent RDP and LDP) were included. The present meta-analysis showed that there were no significant differences in operative time, tumor size, and lymph node dissection between RDP and LDP group. Nevertheless, compared with the LDP group, RDP results seem to demonstrate a possibility in higher R0 resection rate (p<0.0001).

conclusionsThis systematic review and meta-analysis suggest that RDP is a technically and oncologically safe and feasible approach for selected PDAC patients. Large randomized and controlled prospective studies are needed to confirm this data. SYSTEMATIC REVIEW REGISTRATION: https://www.crd.york.ac.uk/PROSPERO/#recordDetails, identifier [CRD42021269353].

Indexed as

distal pancreatectomylaparoscopicmeta-analysispancreatic ductal adenocarcinomarobotic

Identifiers

PMID34616686
PMCPMC8489404
OpenAlexW3198960719

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.